EMulate Therapeutics, Inc. (EMTX)
EMulate Therapeutics was planning to go public, but the IPO was withdrawn on Jul 31, 2024.
IPO Price Range
$4.00 - $6.00
Shares Offered
2,300,000
Deal Size
$11.50M
EMulate Therapeutics Revenue
EMulate Therapeutics had revenue of $255.00K in the twelve months ending June 30, 2022. In the year 2021, EMulate Therapeutics had annual revenue of $241.00K with 113.27% growth.
Revenue (ttm)
$255.00K
Revenue Growth
+113.27%
P/S Ratio
271.81
Revenue / Employee
$36,429
Employees
7
Market Cap
69.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 241.00K | 128.00K | 113.27% |
| Dec 31, 2020 | 113.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEMTX News
- 2 years ago - Medical device developer EMulate Therapeutics files for a $15 million IPO - Renaissance Capital
- 2 years ago - EMulate Therapeutics IPO Registration Document (S-1) - SEC